MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcin.2023.07.028

Медицинская библиотека · JACC. Cardiovascular interventions · 2023

Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.

Kim Hoyun, Kang Do-Yoon, Ahn Jung-Min, Lee Jinho, Choi Yeonwoo, Hur Seung Ho, Park Hun-Jun, Tresukosol Damras, Kang Woong Chol, Kwon Hyuck Moon, Rha Seung-Woon, Lim Do-Sun, Jeong Myung-Ho, Lee Bong-Ki, Huang He, Lim Young-Hyo, Bae Jang Ho, Kim Byung Ok, Ong Tiong Kiam, Ahn Sung Gyun, Chung Cheol-Hyun, Park Duk-Woo, Park Seung-Jung, BEST Extended Follow-Up Study Investigators

Рандомизированное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Diabetes mellitus is associated with more complex coronary artery diseases. Coronary artery bypass grafting (CABG) is a preferred revascularization strategy over percutaneous coronary intervention (PCI) in diabetics with multivessel coronary artery disease (MVD).

OBJECTIVES

This study sought to examine the different prognostic effects of revascularization strategies according to the diabetes status from the randomized BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trial.

METHODS

Patients (n = 880) with MVD were randomly assigned to undergo PCI with an everolimus-eluting stent vs CABG stratified by diabetics (n = 363) and nondiabetics (n = 517). The primary endpoint was the composite of death, myocardial infarction, or target vessel revascularization during a median follow-up of 11.8 years (IQR: 10.6-12.5 years).

RESULTS

In diabetics, the primary endpoint rate was significantly higher in the PCI group than in the CABG group (43% and 32%; HR: 1.53; 95% CI: 1.12-2.08; P = 0.008). However, in nondiabetics, no significant difference was found between the groups (PCI group, 29%; CABG group, 29%; HR: 0.97; 95% CI: 0.67-1.39; P = 0.86; Pinteraction= 0.009). Irrespective of the presence of diabetes, no significant between-group differences were found in the rate of a safety composite of death, myocardial infarction, or stroke and mortality rate. However, the rate of any repeat revascularization was significantly higher in the PCI group than in the CABG group.

CONCLUSIONS

In diabetics with MVD, CABG was associated with better clinical outcomes than PCI. However, the mortality rate was similar between PCI and CABG irrespective of diabetes status during an extended follow-up. (Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST Extended], NCT05125367; Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST], NCT00997828).

Для цитирования: Kim Hoyun, Kang Do-Yoon, Ahn Jung-Min, Lee Jinho, Choi Yeonwoo, Hur Seung Ho, Park Hun-Jun, Tresukosol Damras, Kang Woong Chol, Kwon Hyuck Moon, Rha Seung-Woon, Lim Do-Sun, Jeong Myung-Ho, Lee Bong-Ki, Huang He, Lim Young-Hyo, Bae Jang Ho, Kim Byung Ok, Ong Tiong Kiam, Ahn Sung Gyun, Chung Cheol-Hyun, Park Duk-Woo, Park Seung-Jung, BEST Extended Follow-Up Study Investigators. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.. JACC. Cardiovascular interventions. 2023. DOI: 10.1016/j.jcin.2023.07.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.